177548-85-5Relevant academic research and scientific papers
Based on isoxazole substitution of benzamide derivatives and anti-prostate cancer drug applications
-
Paragraph 0069; 0187-0189, (2022/01/10)
The present invention discloses a class (I), formula (II) structure based on isoxazole substituted benzamide derivatives and antiprostate cancer drug applications, such isoxazole substituted benzamide derivatives, can effectively inhibit the activity of a
HISTONE DEACETYLASE INHIBITORS
-
Page/Page column 28, (2015/11/03)
Fused bicycle indol, indoline, azoindole, or azoindoline compounds of Formula (I) set forth herein. Also disclosed are pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing the same. Further disclosed is a method for treating cancer, e.g., glioma, prostate cancer, and colorectal cancer, with these compounds.
AMINOALKYLAZOLE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS
-
Page/Page column 31-32, (2009/02/11)
The present invention provides a compound of formula I: and the use thereof for the treatment of a central nervous system disorder related to or affected by the histamine-3 receptor.
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
-
, (2008/06/13)
The invention relates to substituted N-aryl heterocycles and to the physiologically tolerated salts and physiologically functional derivatives thereof. Compounds of the formula I in which the radicals have the stated meanings, the N-oxides and the physiologically tolerated salts thereof and process for the preparation thereof are described. The compounds are suitable for example as anorectic agents.
Heterocyclic compounds, their preparation and their therapeutic use
-
, (2008/06/13)
A compound of formula (I): STR1 wherein Y1, Y2, Y3 and Y4 are each hydrogen, halogen, nitro, cyano, hydroxyl, thiol, amino, alkyl, haloalkyl, alkylthio, a protected or unprotected carboxyl, a protected or unprotected sulfonamide, or tetrazol; one of R1 and R2 is hydrogen, alkyl, aryl, aralkyl, oxazolyl, or a protected or unprotected carboxyl and the other of R1 and R2 is hydrogen, alkyl, aryl or aralkyl; and R3 is hydrogen or an amino protecting group, and pharmaceutically acceptable salts or esters thereof. The compounds are effective for treating dementia, Alzheimer's disease and delirium and are effective as sedatives.
